Globus Medical GMED Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 67.9%+0.5pp | 67.4%+2.1pp | 65.3%+2.6pp | 62.8%+2.2pp | 60.6%+1.7pp | |
| Operating margin | 17.2%+0.9pp | 16.3%+2.9pp | 13.4%+2.7pp | 10.7%+0.6pp | 10.2%+3.6pp | |
| Net margin | 18.9%+0.6pp | 18.3%+3.0pp | 15.3%+1.7pp | 13.6%+6.2pp | 7.4%+3.3pp | |
| EBITDA margin | 26.3%+0.5pp | 25.7%+2.4pp | 23.3%+2.3pp | 21%+0.4pp | 20.7%+4.0pp | |
| Free cash flow margin | 19.7%-0.3pp | 20%-0.9pp | 20.9%+0.8pp | 20.1%-0.7pp | 20.8%+4.7pp | |
| Returns | ||||||
| Return on equity | 13.3%+1.0pp | 12.3%+2.3pp | 10%+1.4pp | 8.6%+4.0pp | 4.6%+2.1pp | |
| Return on assets | 11.6%+1.4pp | 10.2%+1.9pp | 8.3%+1.2pp | 7.2%+3.3pp | 3.8%+1.9pp | |
| Return on invested capital | 11.9%+0.7pp | 11.1%+1.5pp | 9.6%+2.5pp | 7.2%+0.3pp | 6.9%+2.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.6×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Inventory turnover | 1.4×0.0× | 1.4×+0.1× | 1.3×0.0× | 1.3×-0.1× | 1.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 4.6×+0.3× | 4.3×+0.1× | 4.1×+0.1× | 4.1×-0.4× | 4.4×+1.9× | |
| Quick ratio | 3×+0.2× | 2.7×+0.3× | 2.5×+0.2× | 2.3×-0.5× | 2.7×+0.9× | |
| Cash ratio | 1.2×+0.1× | 1.1×+0.3× | 0.8×+0.3× | 0.5×-0.7× | 1.2×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -0.5×0.0× | -0.5×-0.1× | -0.4×-0.2× | -0.2×+0.5× | -0.7×+0.9× | |
| Interest coverage | 42.4×-12.0× | 54.4×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $34.24+2.6% | $33.37+2.7% | $32.49+3.2% | $31.47+7.6% | $29.25-3.5% | |
| Valuation | ||||||
| Market capitalization | $11.65B-0.3% | $11.69B+51.1% | $7.73B-2.6% | $7.94B-21.1% | $10.07B-10.6% | |
| Enterprise value | $11.21B-0.6% | $11.28B+50.7% | $7.48B-4.5% | $7.83B-19.2% | $9.7B-8.3% | |
| Price / earnings | 19.9×-1.9× | 21.7×+3.5× | 18.3×-4.0× | 22.3×-32.0× | 54.3×-55.1× | |
| Price / sales | 3.8×-0.2× | 4×+1.2× | 2.8×-0.2× | 3×-1.0× | 4×-0.5× | |
| Price / book | 2.5×-0.1× | 2.6×+0.8× | 1.8×-0.1× | 1.8×-0.6× | 2.5×-0.2× | |
| EV / EBITDA | 13.8×-1.1× | 14.9×+3.3× | 11.6×-2.6× | 14.2×-4.5× | 18.7×-6.5× | |
| EV / sales | 3.6×-0.2× | 3.8×+1.1× | 2.7×-0.3× | 3×-0.9× | 3.9×-0.3× | |
| Free cash flow yield | 5.2%+0.2pp | 5%-2.5pp | 7.5%+0.9pp | 6.6%+1.5pp | 5.2%+1.6pp | |
| Earnings yield | 5%+0.4pp | 4.6%-0.9pp | 5.5%+1.0pp | 4.5%+2.6pp | 1.8%+0.9pp | |
| PEG ratio | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0×-0.3× | 0.3×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Globus Medical's profit margins?
- Globus Medical (GMED) runs a 67.9% gross margin and a 17.2% operating margin, with a 18.9% net margin.
- Where do Globus Medical's ratios come from?
- Every ratio is computed from Globus Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
